Education
About Us
Working with TipRanks
Follow Us
Neogen (NEOG)
NASDAQ:NEOG
NEOG Analyst Ratings
Moderate Buy
2 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NEOG Stock 12 Month Forecast
Average Price Target
$8.17
▲(14.27% Upside)
| Highest Price Target$10.00 | Average Price Target$8.17 | Lowest Price Target$6.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
CJS Securities
$10
Buy
39.86%
Upside
Upgraded
12/10/25
William Blair
―
Hold
―
Reiterated
11/20/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (NASDAQ: REGN) and Neogen (NASDAQ: NEOG)We categorize Nassif’s efforts into two buckets: 1) near- term efforts to stabilize the business, and 2) medium- to long-term efforts that can help unlock Neogen’s full potential. In the near term, Nassif has already started to put his fingerprint on the organization with new commercial structures, more frequent and deliberate operations meetings, and leadership changes (new leaders but also redefined roles). Looking past the next couple of quarters, after the business stabilizes, the focus shifts to ensuring Neogen is positioned to win in key markets.
Piper Sandler
$5→$6.5
Hold
-9.09%
Downside
Reiterated
10/16/25
Guggenheim
$8
Buy
11.89%
Upside
Reiterated
10/09/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
CJS Securities
$10
Buy
39.86%
Upside
Upgraded
12/10/25
William Blair
―
Hold
―
Reiterated
11/20/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (NASDAQ: REGN) and Neogen (NASDAQ: NEOG)We categorize Nassif’s efforts into two buckets: 1) near- term efforts to stabilize the business, and 2) medium- to long-term efforts that can help unlock Neogen’s full potential. In the near term, Nassif has already started to put his fingerprint on the organization with new commercial structures, more frequent and deliberate operations meetings, and leadership changes (new leaders but also redefined roles). Looking past the next couple of quarters, after the business stabilizes, the focus shifts to ensuring Neogen is positioned to win in key markets.
Piper Sandler
$5→$6.5
Hold
-9.09%
Downside
Reiterated
10/16/25
Guggenheim
$8
Buy
11.89%
Upside
Reiterated
10/09/25
Best Analysts Covering Neogen
1 Month
xxx
Success Rate
1/4 ratings generated profit
Average Return
-1.27%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 25.00% of your transactions generating a profit, with an average return of -1.27% per trade.
3 Months
xxx
Success Rate
2/4 ratings generated profit
Average Return
+0.35%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.35% per trade.
1 Year
Success Rate
3/4 ratings generated profit
Average Return
+11.13%
reiterated a buy rating 3 months ago
Copying Subbu Nambi's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +11.13% per trade.
2 Years
xxx
Success Rate
3/4 ratings generated profit
Average Return
+11.13%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +11.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NEOG Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
1
0
0
0
0
Buy
3
1
1
1
2
Hold
5
8
11
11
7
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
9
9
12
13
10
Each month's total comprises the sum of three months' worth of ratings.
NEOG Financial Forecast
NEOG Stock Forecast FAQ
What is NEOG’s average 12-month price target, according to analysts?
Based on analyst ratings, Neogen’s 12-month average price target is 8.17.
What is NEOG’s upside potential, based on the analysts’ average price target?
Neogen has 14.27% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NEOG a Buy, Sell or Hold?
Neogen has a consensus rating of Moderate Buy which is based on 2 buy ratings, 2 hold ratings and 0 sell ratings.
What is Neogen’s price target?
The average price target for Neogen is 8.17. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $10.00 ,the lowest forecast is $6.50. The average price target represents 14.27% Increase from the current price of $7.15.
The highest analyst price target is $10.00 ,the lowest forecast is $6.50. The average price target represents 14.27% Increase from the current price of $7.15.
What do analysts say about Neogen?
Neogen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of NEOG?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.